Sheridan Capital Partners Invests in RS&A
Retrieved on:
Wednesday, June 22, 2022
Professional Services, Oncology, Medical Devices, Health, Finance, Radiology, GPO, Audubon Manning Veterinary Clinic (AMVC), Radiation, Kroll Inc., CEO, Company, McGuireWoods, LLC, Cancer, RSA, DJ, Hospital, ISP, Growth, Maintenance, University, Partnership, Patient, Health, Rural Hall, APriori Capital Partners, Pharmaceutical industry, Medicine
Sheridan Capital Partners (Sheridan) announced today its investment in RS&A, LLC (RSA), an established medical device independent service provider (ISP) based out of Rural Hall, NC.
Key Points:
- Sheridan Capital Partners (Sheridan) announced today its investment in RS&A, LLC (RSA), an established medical device independent service provider (ISP) based out of Rural Hall, NC.
- The transaction was led by Sean Dempsey, Nicholas Rowland, Matt Collins, and Liam McDonald at Sheridan Capital Partners.
- McGuire Woods LLP served as legal counsel to Sheridan Capital Partners.
- Sheridan Capital Partners is a Chicago-based healthcare private equity firm that focuses on lower middle market buyouts and growth equity in the U.S. and Canada.